LEP and breast cancer: Using co-injections of breast cancer cells and adipocytes or pre-adipocytes into nude mice, BMP9 was found to inhibit the growth and metastasis of breast cancer cells, which may be in part related to their interaction with pre-adipocytes or adipocytes via leptin signaling [71].